Cargando…
Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis
The COVID-19 pandemic poses a challenge to health systems worldwide. Limiting healthcare availability may delay early diagnosis and worsen the treatment effects of various diseases, including oncological diseases. We analyzed patients presenting to the 2nd Department of Lung Diseases and Tuberculosi...
Autores principales: | Mojsak, Damian, Dębczyński, Michał, Kuklińska, Beata, Minarowski, Łukasz, Kasiukiewicz, Agnieszka, Moniuszko-Malinowska, Anna, Czupryna, Piotr, Mróz, Robert Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866646/ https://www.ncbi.nlm.nih.gov/pubmed/36674340 http://dx.doi.org/10.3390/ijerph20021583 |
Ejemplares similares
-
The Many Faces of Immune Checkpoint Inhibitor-Associated Pneumonitis: 4 Case Reports
por: Mojsak, Damian, et al.
Publicado: (2022) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Mojsak, Damian, et al.
Publicado: (2021) -
A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin
por: Dębczyński, Michał, et al.
Publicado: (2022) -
Neuroinfection as a Mask of Lung Cancer: A Case Series
por: Kuklińska, Beata, et al.
Publicado: (2016) -
Assessment of Pulmonary Function Tests in COVID-19 Convalescents Six Months after Infection
por: Guziejko, Katarzyna, et al.
Publicado: (2022)